mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.0094 |
0.9 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.9 |